Human Anti-BTN3A1 Recombinant Antibody (clone CTX-2026) (CAT#: VS-0524-YC3)

Clone CTX-2026 is a novel human antibody targeting BTN3A1. CTX-2026 partially share an overlapping epitope with anti-BTN3A1 mAb 20.1. Clone CTX-2026 is effective at restoring pMHC:TCR. CTX-2026 also blocked human BTN3A1-mediated suppression of mouse αβ T-cells. CTX-2026 is sufficient to elicit coordinated αβ and γδ T-cell anti-tumor responses.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG
  • Specificity
  • Human Butyrophilin Subfamily 3 Member A1 (BTN3A1)
  • Species Reactivity
  • Human
  • Clone
  • CTX-2026
  • Applications
  • ELISA, Block, FuncS
  • Related Disease
  • Tumors

Product Property

  • Purification
  • Protein A purified
  • Purity
  • >95%
  • Buffer
  • PBS, pH 7.4
  • Preservative
  • No preservative
  • Storage
  • Centrifuge briefly prior to opening vial. Store at 4°C for short term (1-2 weeks). Aliquot and store at -20°C for long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • CTX-2026 (1 μg/mL) enhanced antigen-specific killing of NY-ESO-1-transduced, HLA-A2⁺BTN3A1⁺ OVCAR3 cells (NY-OVCAR3).
    CTX-2026 (1 μg/mL) heightened cytotoxic elimination of BTN3A1⁺ primary cancer cells from 3 HGSOCs by autologous tumor-infiltrating lymphocytes.
    CTX-2026 (1 μg/mL) re-directed the cytotoxic activity of Vγ9Vδ2 T-cells from multiple donors against BTN3A1⁺ OVCAR3 cells, or primary HGSOC cells.
    CTX-2026 (5mg/kg; i.p.) delayed malignant progression in donors by blocking BTN3A1.
    CTX-2026 (5mg/kg; i.p.) blocked human BTN3A1-mediated suppression of mouse αβ T-cells.

Target

  • Alternative Names
  • Butyrophilin Subfamily 3 Member A1; BTF5; DJ45P21.3 (Butyrophilin, Subfamily 3, Member A1); Butyrophilin, Subfamily 3, Member A1; CD277 Antigen; BTN3.1; BT3.1; CD277;
  • Long Name
  • Butyrophilin Subfamily 3 Member A1
  • Sequence Similarities
  • Belongs to the immunoglobulin superfamily. BTN/MOG family.
  • Cellular Localization
  • Cell membrane
  • Post Translation Modifications
  • N-glycosylation
    Glycosylation at Asn115
  • Function
  • Regulates the proliferation of activated T-cells.
    Regulates the release of cytokines and IFNG by activated T-cells.
    Mediates the response of T-cells toward infected and transformed cells that are characterized by high levels of phosphorylated metabolites.

Recommended Products

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "BTN3A1"

Select a product category from the dropdown menu below to view related products.
Please select product type
Fab Antibody Products ScFv Antibody Products IgG Antibody Products Mouse Antibody Products Flow Cytometry (FC) related Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-0524-YC3. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare